BetterScholar BetterScholar
10
Role
Title
Level Year L/R
🐒 COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience
48 auth. A. Shields, S. Burns, S. Savic, A. Richter, A. Anantharachagan, G. Arumugakani, K. Baker, S. Bahal, W. Bermingham, Malini V. Bhole, E. Boules, P. Bright, S. Burns, Betsy Cleave, J. Dempster, ... L. Devlin, Fatima Dhalla, E. Drewe, C. Duncan, M. Dziadzio, S. Elkhalifa, A. Gennery, S. Goddard, S. Grigoriadou, G. Hayman, A. Herwadkar, A. Huissoon, R. Jain, S. Jolles, S. Johnston, L. Leeman, S. Mahabir, D. MacLochlainn, E. McDermott, S. Misbah, H. Morsi, S. Murng, S. Noorani, R. O’Brien, Smita Y. Patel, A. Price, A. Richter, S. Seneviratne, A. Shields, A. Shrimpton, C. Stroud, P. Vaitla, N. Verma
7 2020
7
🐒
🐜 Arl13b-regulated cilia activities are essential for polarized radial glial scaffold formation
11 auth. Holden Higginbotham, Jiami Guo, Yukako Yokota, Nicole L. Umberger, C. Su, Jingjun Li, ... N. Verma, Joshua Hirt, V. Ghukasyan, T. Caspary, E. S. Anton
7 2013
7
🐜
🦁 Recent advances in the use of Sus scrofa (pig) as a model system for proteomic studies
N. Verma, A. Rettenmeier, S. Schmitz‐Spanke
7 2011
7
🦁
🐜 British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders.
35 auth. J. Hurst, N. Verma, D. Lowe, H. Baxendale, S. Jolles, P. Kelleher, H. Longhurst, Smita Y. Patel, E. Renzoni, C. Sander, G. Avery, J. Babar, M. Buckland, S. Burns, W. Egner, ... M. Gompels, Pavels Gordins, J. Haddock, S. Hart, G. Hayman, R. Herriot, R. Hoyles, A. Huissoon, J. Jacob, A. Nicholson, D. Rassl, R. Sargur, S. Savic, S. Seneviratne, M. Sheaff, P. Vaitla, G. Walters, J. Whitehouse, P. Wright, Alison M. Condliffe
7 2017
7
🐜
🐜 Improving the thermoelectric properties of half-Heusler TiNiSn through inclusion of a second full-Heusler phase: microwave preparation and spark plasma sintering of TiNi(1+x)Sn.
9 auth. Christina S. Birkel, J. Douglas, Bethany R. Lettiere, G. Seward, N. Verma, Yichi Zhang, ... T. Pollock, R. Seshadri, G. Stucky
6 2013
6
🐜
🦁 Immune deficiency and autoimmunity in patients with CTLA‐4 (CD152) mutations
N. Verma, S. Burns, Lucy S K Walker, D. Sansom
6 2017
6
🦁
🦁 Review on proteomic analyses of benzo[a]pyrene toxicity
N. Verma, M. Pink, A. Rettenmeier, S. Schmitz‐Spanke
6 2012
6
🦁
🐬 Interaction of yttrium disilicate environmental barrier coatings with calcium-magnesium-iron alumino-silicate melts
David L. Poerschke, J. Shaw, N. Verma, F. Zok, C. Levi
6 2018
6
🐬
🐜 Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations.
20 auth. T. Hou, N. Verma, J. Wanders, A. Kennedy, B. Soskic, D. Janman, Neil Halliday, Behzad Rowshanravan, A. Worth, W. Qasim, ... H. Baxendale, H. Stauss, S. Seneviratne, O. Neth, P. Olbrich, S. Hambleton, P. Arkwright, S. Burns, L. Walker, D. Sansom
6 2017
6
🐜
🐜 Phase stability and property evolution of biphasic Ti–Ni–Sn alloys for use in thermoelectric applications
8 auth. J. Douglas, Christina S. Birkel, N. Verma, V. Miller, M. Miao, G. Stucky, ... T. Pollock, R. Seshadri
6 2014
6
🐜